lighting the<br><span>world blue</span>

lighting the
world blue

In honor of Mesothelioma Awareness Day on Sept. 26, we arranged for buildings and landmarks in U.S. cities to light blue, the official color of mesothelioma awareness.

learn more
clinical trial<br><span>collaboration</span>

clinical trial
collaboration

We entered into a clinical trial collaboration agreement with Roche to evaluate Tumor Treating Fields as part of a novel combination for the first-line treatment of metastatic pancreatic cancer.

learn more
breakthrough<br><span> device designation</span>

breakthrough
device designation

The FDA granted breakthrough designation to the NovoTTF-200T System™ intended for use together with atezolizumab and bevacizumab for the first-line treatment of patients with unresectable or metastatic liver cancer.

learn more
top workplace<br><span> in New Hampshire</span>

top workplace
in New Hampshire

We’ve been recognized as a top employer in New Hampshire, where our U.S. Operations Center is based. Learn more about what makes working at Novocure special.

learn more
Q2 financial results

Q2 financial results

We reported second quarter financial results for 2021, highlighting commercial strength and strategic investment across clinical, product development and commercial initiatives intended to fuel future growth of the company.

learn more

the story
of Novocure

We are a global oncology company striving to extend survival in some of the most aggressive forms of cancer. In 2000, our founder Professor Yoram Palti sought to leverage his expertise in biophysics to develop a new way to treat cancer that would destroy tumor cells while sparing healthy tissue and avoiding many of the life-altering side effects of existing cancer therapies. Novocure has grown into an international oncology company with more than 1,000 employees and operations in the U.S., Europe and Asia. With more than 20 years of research and many significant milestones, we believe we are only beginning.

Learn More

we can leverage physics to fight cancer

Tumor Treating Fields is a cancer therapy that uses electric fields to disrupt cancer cell division.

OUR THERAPY

explore our clinical pipeline

Our research shows that Tumor Treating Fields have an antimitotic effect in more than 18 solid tumor types in culture and in eight in vivo tumor models.

OUR PIPELINE

we are dedicated to making a difference in cancer

Patients remain at the heart of the work we do every day. Learn more about our patients, their families and the people working to deliver patient-forward therapies to treat cancer.

PATIENT-FORWARD